BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 16627007)

  • 21. [Effects of Ginkgo biloba extract in improving episodic memory of patients with mild cognitive impairment: a randomized controlled trial].
    Zhao MX; Dong ZH; Yu ZH; Xiao SY; Li YM
    Zhong Xi Yi Jie He Xue Bao; 2012 Jun; 10(6):628-34. PubMed ID: 22704410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials.
    Savaskan E; Mueller H; Hoerr R; von Gunten A; Gauthier S
    Int Psychogeriatr; 2018 Mar; 30(3):285-293. PubMed ID: 28931444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
    Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ginkgo biloba extract EGb 761® in the context of current developments in the diagnosis and treatment of age-related cognitive decline and Alzheimer's disease: a research perspective.
    Lautenschlager NT; Ihl R; Müller WE
    Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S46-50. PubMed ID: 22784429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study.
    Bettermann K; Arnold AM; Williamson J; Rapp S; Sink K; Toole JF; Carlson MC; Yasar S; Dekosky S; Burke GL
    J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):436-44. PubMed ID: 21236699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of Ginkgo biloba extract in acute ischemic stroke.
    Liu J
    Explore (NY); 2006 May; 2(3):262-3. PubMed ID: 16781654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of standardized ginkgo biloba extract on cognitive symptoms of dementia with a six-month treatment: a bivariate random effect meta-analysis.
    Wang BS; Wang H; Song YY; Qi H; Rong ZX; Wang BS; Zhang L; Chen HZ
    Pharmacopsychiatry; 2010 May; 43(3):86-91. PubMed ID: 20104449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Ginkgo biloba on dementia: An overview of systematic reviews.
    Yuan Q; Wang CW; Shi J; Lin ZX
    J Ethnopharmacol; 2017 Jan; 195():1-9. PubMed ID: 27940086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial.
    Johnson SK; Diamond BJ; Rausch S; Kaufman M; Shiflett SC; Graves L
    Explore (NY); 2006 Jan; 2(1):19-24. PubMed ID: 16781604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasodilators and nootropics as predictors of dementia and mortality in the PAQUID cohort.
    Dartigues JF; Carcaillon L; Helmer C; Lechevallier N; Lafuma A; Khoshnood B
    J Am Geriatr Soc; 2007 Mar; 55(3):395-9. PubMed ID: 17341242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and Safety Profile of Ginkgo biloba Standardized Extract (EGb761®) in Patients with Amnestic Mild Cognitive Impairment.
    Băjenaru O; Prada G; Antochi F; Jianu C; Tudose C; Cuciureanu A; Docu AA; Perrot V; Avram M; Tiu C
    CNS Neurol Disord Drug Targets; 2021; 20(4):378-384. PubMed ID: 33557741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A comparison of cholinesterase inhibitors and ginkgo extract in treatment of Alzheimer dementia].
    Schreiter Gasser U; Gasser T
    Fortschr Med Orig; 2001 Nov; 119(3-4):135-8. PubMed ID: 11789125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plant-based nutraceutical interventions against cognitive impairment and dementia: meta-analytic evidence of efficacy of a standardized Gingko biloba extract.
    Solfrizzi V; Panza F
    J Alzheimers Dis; 2015; 43(2):605-11. PubMed ID: 25352453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Ginkgo biloba extract EGb 761 ® in dementia with neuropsychiatric features: review of recently completed randomised, controlled trials.
    Ihl R
    Int J Psychiatry Clin Pract; 2013 Nov; 17 Suppl 1():8-14. PubMed ID: 23808613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Cognition Support Formula® on cognitive function in older adults with subjective cognitive impairment: a protocol for a 26-week, randomised, double-blind, placebo-controlled trial.
    Cave AE; Chang DH; Münch GW; Steiner GZ
    Trials; 2019 Jun; 20(1):345. PubMed ID: 31182153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Yang G; Wang Y; Sun J; Zhang K; Liu J
    Curr Top Med Chem; 2016; 16(5):520-8. PubMed ID: 26268332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.
    Schneider LS; DeKosky ST; Farlow MR; Tariot PN; Hoerr R; Kieser M
    Curr Alzheimer Res; 2005 Dec; 2(5):541-51. PubMed ID: 16375657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial.
    Ihl R; Tribanek M; Bachinskaya N
    J Neurol Sci; 2010 Dec; 299(1-2):184-7. PubMed ID: 20837354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB
    Hum Psychopharmacol; 2007 Dec; 22(8):559-66. PubMed ID: 17902186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ginkgo biloba does not improve cognitive function in MS: a randomized placebo-controlled trial.
    Lovera JF; Kim E; Heriza E; Fitzpatrick M; Hunziker J; Turner AP; Adams J; Stover T; Sangeorzan A; Sloan A; Howieson D; Wild K; Haselkorn J; Bourdette D
    Neurology; 2012 Sep; 79(12):1278-84. PubMed ID: 22955125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.